Effect of Perch Essence on Cognitive Function Status in Subjects With Mild Cognitive Impairment
NCT07239635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2025-11-20
Summary
With global population aging, cognitive impairment and dementia have become major public health issues worldwide. According to the 2019 World Alzheimer Report by the Alzheimer's Disease International, there are more than 50 million people living with dementia globally, and this number is projected to rise to 152 million by 2050, with one new case occurring every three seconds. Our research is to investigate the intervention effects of perch essence on cognitive function in mild-cognitive impairment patients.
1\. Study population: 54 MCI patients were recruited and the inclusion criteria are: (1) aged ≥ 45, (2) diagnosed with mild cognitive impairment by clinical dementia rating (CDR) with a scoring of 0.5, and (3) have the ability to communicate, reading and writing. The exclusion criteria are: (1) diagnosed with dementia, (2) diagnosed with terminal diseases or severe psychological symptoms (lifespan ≤ 2 years, cancer, severe stroke, heart disease, liver cirrhosis, ESRD, severe depression, etc.), (3) Severe blindness, hearing impairment, or communication disability, (4) Branched-chain organic aciduria (e.g., maple syrup urine disease), (5) Individuals who do not consume fish or are allergic to fish products 2. Study design: A two-arm single-blind randomized controlled clinical trial will be performed for 24 weeks and the subjects will be divided in to 2 groups: (1) control group, (2) treatment group. S The treatment group were asked to consume 60mL/packet of perch essence, twice daily for 24 weeks, whereas the control group were provided with the same appearance, flavor, and color of fish stock. Participants were asked to maintain their dietary habit, lifestyle, and used of medication.
3\. Outcome assessment:
1. Anthropometry data: height, weight, body mass index
2. Blood biochemistry:
A. Nutritional status: albumin, total protein, Vitamin B12, folate, magnesium B. Glycemic profiles: fasting blood glucose C. Lipid profiles: total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG).
D. Complete blood counts: white blood cells (WBC), red blood cells (RBC), hemoglobin (HB), platelet count (PLT), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC).
E. Brain derived neurotrophic factor (BDNF), malondialdehyde (MDA)
3. Urine test Urine color, appearance, specific gravity, pH, glucose, creatinine
4. Cognitive function: Montreal cognitive assessment (MoCA), Cognitive abilities screening instruments (CASI)
5. Nutrition status Mini-nutritional assessments (MNA), 3-day dietary recall The purpose of the study investigated the intervention of perch essence supplement on cognitive function and its correlation with nutritional status in MCI patients.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Perch essence
60mL/packet of perch essence, twice daily for 24 weeks
- DIETARY_SUPPLEMENT
-
Fish stock
60mL/packet of fish stock, twice daily for 24 weeks, with the same appearance, flavor, and color compared to perch essence
Sponsors & Collaborators
-
Taipei Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-16
- Primary Completion
- 2025-03-25
- Completion
- 2025-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.
NCT06770309 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
NCT07250035 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment
NCT04596072 ·Status: COMPLETED ·Phase: NA
-
Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke
NCT02176395 ·Status: COMPLETED ·Phase: PHASE4
-
Oriental Intervention for Enhanced Neurocognitive Health (Orient) Diet in Populations With High Risk of Stroke (ENDS)
NCT06098235 ·Status: RECRUITING ·Phase: NA
-
Effect of Computer-based Cognitive Function Training on Cognitive Dysphagia After Stroke
NCT06303882 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Protein Supplementation for Chronic Stroke Treatment
NCT03637270 ·Status: COMPLETED ·Phase: NA
-
the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI
NCT06313866 ·Status: RECRUITING ·Phase: NA
-
Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients
NCT03945526 ·Status: COMPLETED ·Phase: PHASE1
-
Preventive Effects of Ginseng Against Atherosclerosis
NCT02796664 ·Status: COMPLETED ·Phase: NA
-
Effects of Gargling With Green Tea on Oral Health of Stroke Patients
NCT05037721 ·Status: UNKNOWN ·Phase: NA
-
Development and Validation of the Prediction Model for Cognitive Impairment
NCT05465980 ·Status: UNKNOWN
-
Effects of Intravascular Laser Irradiation of Blood for Mitochondral Dysfunction in Cerebral Ischemic Stroke
NCT06932627 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
NCT01758536 ·Status: UNKNOWN ·Phase: PHASE4
-
Nut Supplementation to Mitigate Post-stroke Cognitive Decline
NCT05902767 ·Status: SUSPENDED ·Phase: NA
-
Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke
NCT06140888 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients
NCT06549582 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MIND Diet to Improve Cognitive Function in Mild Stroke Patients
NCT05921084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Plan of Ischemic Stroke
NCT04953663 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Study in the Correlation Between the Severity of Post-stroke Fatigue and the Severity of qi Deficiency and Blood Stasis
NCT01669759 ·Status: UNKNOWN
-
A Research of Application of the New Model of Standardized Secondary Prevention of Stroke
NCT05757635 ·Status: NOT_YET_RECRUITING
-
Taiwan Post-Stroke Disability Study
NCT06772194 ·Status: RECRUITING
-
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
NCT07220538 ·Status: RECRUITING ·Phase: PHASE4
-
Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome
NCT04492241 ·Status: UNKNOWN ·Phase: NA
-
Silkworm Pupa Powder Improves Dementia.
NCT06898476 ·Status: RECRUITING ·Phase: NA